Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

The Path to Progress

At the crossroad between epigenetics and protein homeostasis, the cellular roles of ubiquitin proteasome pathways are emerging as very attractive targets for novel drug discovery opportunities in many therapeutic disease indications

Xavier Jacq and Niall Martin, MISSION Therapeutics, (December 2013)

Keywords: Ubiquitin pathways, Deubiquitylating enzyme (DUB), DNA damage response (DDR)

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |